The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells.
about
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisMigration and invasion of drug-resistant lung adenocarcinoma cells are dependent on mitochondrial activityGerosuppressant metformin: less is moreEffects of metformin on CD133+ colorectal cancer cells in diabetic patientsIn vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsMetformin: multi-faceted protection against cancer.Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasisMetformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosisBasal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).Weight loss reduces basal-like breast cancer through kinome reprogrammingRepositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drugMetformin targets multiple signaling pathways in cancer.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women.Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers.Downregulation of CD24 suppresses bone metastasis of lung cancer.
P2860
Q28388257-655FFC39-6792-4999-835C-A4466FDDBF44Q30833290-12A69919-15E0-4A7A-A9B6-2AF5FBBBC48AQ35052060-FF2ED74C-C89C-45C4-ACAD-BC95DCCACE27Q35053962-86B8EDB8-0D61-4C1E-A4D2-3ABB6DE2CFA2Q35425337-C4F2F450-37AA-4FF8-9D59-3A94D67EB9D1Q35764409-E78335F0-BFA1-4CC8-A020-EE6735B1AA33Q36026661-34F088FD-C673-4026-96BF-E5FED2D3D64BQ36516580-3D445FBE-5A70-4D97-A5CB-2142F1B76B38Q36618624-ADE56233-BE4E-48D4-844D-E03CBE7E0A5EQ36758643-E6B9EBF1-57B3-41B1-AB31-57D51D9A7DD1Q37091483-8F19347D-B96D-414F-8EC7-22CBC70CDC67Q37501673-BAAE7973-68E2-464F-B9D7-4E1EF8938CA2Q37609790-120268A3-ABA6-4DC6-8419-366B55EFDA2AQ37610799-E7E1B6F7-D890-4FF1-BCA5-224DC4D51EFEQ38976502-550F76DE-B17D-4866-877E-E4646AE03925Q41471175-70037E57-0127-4149-B347-83C6B4FF8336Q47449898-08E0E4C4-A1E8-4D5D-99A2-386231631054
P2860
The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The anti-diabetic drug metform ...... -negative breast cancer cells.
@en
The anti-diabetic drug metform ...... -negative breast cancer cells.
@nl
type
label
The anti-diabetic drug metform ...... -negative breast cancer cells.
@en
The anti-diabetic drug metform ...... -negative breast cancer cells.
@nl
prefLabel
The anti-diabetic drug metform ...... -negative breast cancer cells.
@en
The anti-diabetic drug metform ...... -negative breast cancer cells.
@nl
P2093
P1433
P1476
The anti-diabetic drug metform ...... e-negative breast cancer cells
@en
P2093
Alejandro Vazquez-Martin
Begoña Martin-Castillo
Cristina Oliveras-Ferraros
Eugeni Lopez-Bonet
Javier A Menendez
Silvia Cufí
Sonia Del Barco
P304
P577
2011-01-01T00:00:00Z